K2 Therapeutics
Tracked across 1 events · 6 articles · First seen Jul 20, 2026 · Last active Aug 19, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: K2 Therapeutics has licensed an Antengene TCE candidate, gaining access to a promising asset.
Jul 20, 2026 · 6 articles
ERGEN INTELLIGENCE
Track K2 Therapeutics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard